Ronald Gust

10.8k total citations · 3 hit papers
271 papers, 9.4k citations indexed

About

Ronald Gust is a scholar working on Organic Chemistry, Oncology and Molecular Biology. According to data from OpenAlex, Ronald Gust has authored 271 papers receiving a total of 9.4k indexed citations (citations by other indexed papers that have themselves been cited), including 156 papers in Organic Chemistry, 136 papers in Oncology and 68 papers in Molecular Biology. Recurrent topics in Ronald Gust's work include Metal complexes synthesis and properties (116 papers), Ferrocene Chemistry and Applications (67 papers) and Click Chemistry and Applications (34 papers). Ronald Gust is often cited by papers focused on Metal complexes synthesis and properties (116 papers), Ferrocene Chemistry and Applications (67 papers) and Click Chemistry and Applications (34 papers). Ronald Gust collaborates with scholars based in Germany, Austria and France. Ronald Gust's co-authors include Ingo Ott, Wukun Liu, Brigitte Kircher, William S. Sheldrick, Ulrich Abram, Kerstin Bensdorf, Ulrich Schatzschneider, Kathrin Schmidt, Helmut Schönenberger and Thomas Wiglenda and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Chemical Society Reviews and Angewandte Chemie International Edition.

In The Last Decade

Ronald Gust

268 papers receiving 9.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Metal N-heterocyclic carbene complexes as potential antitumor metallodrugs

2012 668 citations Wukun Liu, Ronald Gust Chemical Society Reviews profile →
Non Platinum Metal Complexes as Anti‐cancer Drugs

2007 525 citations Ingo Ott, Ronald Gust Archiv der Pharmazie profile →
Recent development of gold(i) and gold(iii) complexes as therapeutic agents for cancer diseases

2022 179 citations Yunlong Lu, Xiaoyan Ma et al. Chemical Society Reviews profile →

Peers

Countries citing papers authored by Ronald Gust

Since Specialization

Citations

This map shows the geographic impact of Ronald Gust's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald Gust with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald Gust more than expected).

Fields of papers citing papers by Ronald Gust

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald Gust. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald Gust. The network helps show where Ronald Gust may publish in the future.

Co-authorship network of co-authors of Ronald Gust

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald Gust. A scholar is included among the top collaborators of Ronald Gust based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald Gust. Ronald Gust is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Key determinants of the chemo-sensitizing activity of novel Telmisartan derivatives 2025 ·European Journal of Medicinal Chemistry Reports ·Mathias Gebhart, (unknown), (unknown), (unknown), Stefan Schwaiger, (unknown), Ronald Gust, Stefan Salcher	1
2	Circumventing Imatinib resistance in CML: Novel Telmisartan-based cell death modulators with improved activity and stability 2024 ·European Journal of Medicinal Chemistry ·M Gebhart, Mostafa Alilou, Ronald Gust, Stefan Salcher	1
3	Development of Zeise’s Salt Derivatives Bearing Substituted Acetylsalicylic Acid Substructures as Cytotoxic COX Inhibitors 2023 ·Pharmaceutics ·(unknown), (unknown), (unknown), J. Egger, (unknown), Qianqian Qiu, (unknown), (unknown), Klaus Wurst, Daniel Baecker, Ronald Gust	4
4	Structure–activity relationship study to improve cytotoxicity and selectivity of lonafarnib against breast cancer cells 2023 ·Archiv der Pharmazie ·(unknown), Ronald Gust	2
5	Synthesis and biological evaluation of salophen nickel(II) and cobalt(III) complexes as potential anticancer compounds 2023 ·Archiv der Pharmazie ·(unknown), Daniel Baecker, (unknown), (unknown), Martin Hermann, Brigitte Kircher, Ronald Gust	13
6	Amino Acids as Chelating Ligands for Platinum: Enhanced Stability in an Aqueous Environment Promoted by Biocompatible Molecules 2023 ·Journal of Medicinal Chemistry ·(unknown), (unknown), Davide Corinti, Giel Berden, Jos Oomens, Klaus Wurst, Ronald Gust, Maria Elisa Crestoni, Brigitte Kircher, (unknown)	2
7	Recent development of gold(i) and gold(iii) complexes as therapeutic agents for cancer diseases breakdown → 2022 ·Chemical Society Reviews ·Yunlong Lu, Xiaoyan Ma, (unknown), (unknown), Lin Lv, Min Shan, Qiuyue Lu, Zhenfan Wen, Ronald Gust, Wukun Liu	179
8	Initial In Vitro and In Vivo Evaluation of a Novel CCK2R Targeting Peptide Analog Labeled with Lutetium-177 2020 ·Molecules ·(unknown), (unknown), (unknown), (unknown), Ronald Gust, Soraya Shahhosseini, Elisabeth von Guggenberg	12
9	The Biological Activity of Zeise’s Salt and its Derivatives 2015 ·Angewandte Chemie International Edition ·(unknown), Maria Stefanopoulou, (unknown), Kerstin Bensdorf, (unknown), William S. Sheldrick, Ronald Gust	18
10	Small cationic antimicrobial peptides delocalize peripheral membrane proteins 2014 ·Proceedings of the National Academy of Sciences ·Michaela Wenzel, Alina Iulia Chiriac, Andreas Otto, Dagmar Zweytick, Caroline May, (unknown), Ronald Gust, Bauke Albada, (unknown), Ute Krämer, Ralf Erdmann, Nils Metzler‐Nolte, Suzana K. Straus, Erhard Bremer, Dörte Becher, Heike Brötz‐Oesterhelt, Hans‐Georg Sahl, Julia E. Bandow	280
11	Investigations on cytotoxicity and anti-inflammatory potency of licofelone derivatives 2011 ·European Journal of Medicinal Chemistry ·Wukun Liu, Jinpei Zhou, Kerstin Bensdorf, Huibin Zhang, Haoran Liu, Yubin Wang, Hai Qian, Yanchun Zhang, (unknown), (unknown), Wenlong Huang, Can‐Cheng Guo, Ronald Gust	34
12	Amyloid beta 42 peptide (Aβ42)-lowering compounds directly bind to Aβ and interfere with amyloid precursor protein (APP) transmembrane dimerization 2010 ·Proceedings of the National Academy of Sciences ·(unknown), Lisa Marie Munter, (unknown), Peter W. Hildebrand, Muralidhar Dasari, (unknown), Bruno Bulic, Michael Beyermann, Ronald Gust, Bernd Reif, Sascha Weggen, Dieter Langosch, Gerd Multhaup	91
13	[N,N′-Bis(salicylidene)-1,2-phenylenediamine]metal complexes with cell death promoting properties 2009 ·JBIC Journal of Biological Inorganic Chemistry ·(unknown), Ingo Ott, Ana Kitanovic, Igor Kitanović, Hamed Alborzinia, (unknown), Stefan Wölfl, Nils Metzler‐Nolte, Sven Schäfer, William S. Sheldrick, Caroline Bischof, Ulrich Schatzschneider, Ronald Gust	84
14	Dinuclear organoiridium(III) mono- and bis-intercalators with rigid bridging ligands: Synthesis, cytotoxicity and DNA binding 2009 ·Journal of Inorganic Biochemistry ·(unknown), (unknown), Ingo Ott, Ronald Gust, Raphael Stoll, William S. Sheldrick	70
15	Non Platinum Metal Complexes as Anti‐cancer Drugs breakdown → 2007 ·Archiv der Pharmazie ·Ingo Ott, Ronald Gust	525
16	Preclinical and Clinical Studies on the Use of Platinum Complexes for Breast Cancer Treatment 2007 ·Anti-Cancer Agents in Medicinal Chemistry ·Ingo Ott, Ronald Gust	67
17	5-Alkynyl-2′-deoxyuridines: Chromatography-free synthesis and cytotoxicity evaluation against human breast cancer cells 2007 ·Bioorganic & Medicinal Chemistry ·(unknown), Ingo Ott, (unknown), Adam Sniady, Ronald Gust, Roman Dembiński	46
18	Paclitaxel-loaded microparticles and implants for the treatment of brain cancer: Preparation and physicochemical characterization 2006 ·International Journal of Pharmaceutics ·K. Elkharraz, N. Faisant, (unknown), F. Siepmann, (unknown), Jean-Michel Oger, Ronald Gust, Achim Goepferich, Jean‐Pierre Benoît, Juergen Siepmann	71
19	[1,2-Bis(2-hydroxyphenyl)ethylenediamine]dichloroplatinum(II), a new compound for the therapy of ovarian cancer 1992 ·Journal of Cancer Research and Clinical Oncology ·Günther Bernhardt, Ronald Gust, Herta Reile, (unknown), Richard Müller, (unknown), Thilo Spruß, Helmut Schönenberger, Thomas Burgemeister, Albrecht Mannschreck, Klaus‐Jürgen Range, Ulrich Klement	8
20	[1,2-Bis(2-hydroxyphenyl)ethylenediamine]dichloroplatinum(II), a new compound for the therapy of ovarian cancer 1992 ·Journal of Cancer Research and Clinical Oncology ·Günther Bernhardt, Ronald Gust, Herta Reile, (unknown), Richard Müller, (unknown), Thilo Spruß, Helmut Schönenberger, Thomas Burgemeister, Albrecht Mannschreck, (unknown), Ulrich Klement	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact